Claims for Patent: 8,501,474

Summary for Patent: 8,501,474

Title:	Methods of generating embryoid bodies and uses of same
Abstract:	Methods of generating embryoid bodies (EBs) by culturing embryonic stem cells (ESCs) under static conditions followed by culturing the cells under dynamic conditions using e.g., a Glass Bulb-shaped Impeller (GBI) or shaking a culture vessel are provided. Also provided are methods of generating expanded and/or differentiated cells from the EBs of the invention and methods of using same for treating disorders requiring cell replacement therapy.
Inventor(s):	Yirme; Galia (Kerem Maharal, IL), Itskovitz-Eldor; Joseph (Haifa, IL)
Assignee:	Technion Research & Development Foundation Limited (Haifa, IL)
Application Number:	12/738,086
Patent Claims:	1. A method of generating human embryoid bodies comprising: (a) dispersing into a culture medium human embryonic stem cell colonies into initiation nucleus foci (INF) (b) culturing said human embryonic stem cells resultant of step (a) at an initial concentration range of at least 0.5.times.10.sup.6+/-10% cells/ml for 2+/-10% days under static conditions; and subsequently (c) culturing said cells resultant of step (b) under dynamic conditions using a Glass Bulb-shaped Impeller (GBI), wherein a growth rate of said cells is at least 1.6 times/day during 6 days of said dynamic conditions, thereby generating the human embryoid bodies at 200+/-10% embryoid bodies per milliliter of culture media from said human embryonic stem cells. 2. The method of claim 1, wherein said dispersing is effected detaching said colonies from a support thereof using type IV Collagenase. 3. The method of claim 1, wherein said static conditions comprise culturing said embryonic stem cells in a Rotating Wall Vessel (RWV) bioreactor. 4. The method of claim 1, wherein said dynamic conditions enable generation of embryoid bodies which include no more than 4% of apoptotic cells following 10 days in culture. 5. The method of claim 1, wherein said embryoid bodies are devoid of necrotic centers. 6. The method of claim 1, wherein an average diameter of said embryoid bodies generated following 10 days in culture does not exceed about 400 .mu.m. 7. The method of claim 1, wherein said dynamic conditions comprise stirring said GBI at a rate of 75 .+-.10% revolutions per minute (RPM). 8. The method of claim 1, wherein cells comprised in said embryoid bodies exhibit normal karyotype. 9. The method of claim 1, wherein said culturing of said embryonic stem cells is effected in a culture medium selected suitable for embryoid bodies formation. 10. The method of claim 9, wherein said culture medium comprises 80% KO-DMEM, 20% serum, 1% Penicillin-Streptomycin, 1 mM L-glutamine, and 1% non-essential amino acid stock. 11. The method of claim 1, wherein said embryoid bodies differentiate into cardiomyocytes. 12. The method of claim 1, wherein said embryoid bodies spontaneously contract when transferred to gelatin-coated plates. 13. The method of claim 1, wherein when said culturing under said dynamic conditions is effected for about 6 days then said culture comprises at least 3.7.times.10.sup.6.+-.10% viable cells/ml. 14. The method of claim 1, wherein said growth rate of said cells is at least 2.3 times/day during 6 days of said dynamic conditions. 15. The method of claim 1, wherein each of said initiation nucleus foci comprises about 1300-1600 of said embryonic stem cells.

Details for Patent 8,501,474

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2027-10-15